Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01629784
Other study ID # STU65095
Secondary ID
Status Completed
Phase N/A
First received June 26, 2012
Last updated April 15, 2013
Start date May 2012
Est. completion date January 2013

Study information

Verified date April 2013
Source Northwestern University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Studies have shown that there are significant differences in severity and outcome of lupus in patients of colored skin compared with Caucasians. There are many factors that lead to this discrepancy: genetics, poverty, education level, as well as behavioral and cultural factors. Cutaneous Lupus Erythematosus (CLE) is a disease of flares and remissions with identifiable triggers. One of the most aggravating triggers in CLE is sun exposure. The investigators hypothesize that there are disparities in knowledge about photoprotection, leading to poorer outcomes in minority ethnic groups. This study aims to assess knowledge of risk factors and triggers, especially sun exposure, and the effects on quality of life of Caucasian and minority populations, by conducting an assessment survey and subsequent teaching intervention on appropriate skin protection techniques including appropriate sun screen application, and use of sun-protective clothing. After three months a survey to evaluate knowledge retention about and the application of the educational intervention will be conducted.


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date January 2013
Est. primary completion date January 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Subjects with a diagnosis of cutaneous lupus erythematous

- Subjects ages 18 years of age and older and able to give consent

Exclusion Criteria:

- That which does not fit the inclusion criteria

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label


Intervention

Behavioral:
Cutaneous Lupus educational script
Subjects will listen to a short informational script on Cutaneous lupus and skin protection

Locations

Country Name City State
United States Northwestern University Department of Dermatology Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
Northwestern University

Country where clinical trial is conducted

United States, 

References & Publications (4)

Finlay AY. Quality of life assessments in dermatology. Semin Cutan Med Surg. 1998 Dec;17(4):291-6. Review. — View Citation

Foering K, Goreshi R, Klein R, Okawa J, Rose M, Cucchiara A, Werth VP. Prevalence of self-report photosensitivity in cutaneous lupus erythematosus. J Am Acad Dermatol. 2012 Feb;66(2):220-8. doi: 10.1016/j.jaad.2010.12.006. Epub 2011 Jul 13. — View Citation

Kundu RV, Kamaria M, Ortiz S, West DP, Rademaker AW, Robinson JK. Effectiveness of a knowledge-based intervention for melanoma among those with ethnic skin. J Am Acad Dermatol. 2010 May;62(5):777-84. doi: 10.1016/j.jaad.2009.08.047. Epub 2010 Mar 9. — View Citation

Werth VP. Clinical manifestations of cutaneous lupus erythematosus. Autoimmun Rev. 2005 Jun;4(5):296-302. Epub 2005 Feb 10. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of Subjects Who Correctly Answered a Knowledge Assessment Item Immediately Before and After an Educational Lecture In order to evaluate the immediate effect of an educational lecture about cutaneous lupus erythematosus (CLE) and sun protection, subjects completed a written questionnaire to assess knowledge about CLE and sun protection immediately before and after the educational lecture. The percentage of subjects who correctly answered a knowledge assessment item were calculated pre- and post-educational lecture. immediately before and after an educational lecture No
Secondary Percentage of Subjects Who Correctly Answered a Knowledge or Behavioral Assessment Item Before and 3 Months After an Educational Lecture In order to evaluate the long-term effect of an educational lecture about cutaneous lupus erythematosus (CLE) and sun protection, subjects completed a questionnaire to assess knowledge about CLE and sun protection behaviors immediately before and three months after an educational lecture. The percentage of subjects who correctly answered a knowledge or behavioral assessment item were calculated pre- and three months post-educational lecture. before and 3 months after an educational lecture No
See also
  Status Clinical Trial Phase
Completed NCT01776190 - Low-dose UVA1 Radiation in Cutaneous Lupus Patients N/A
Completed NCT00420173 - Interdisciplinary Study Group of Lupus Erythematosus (ISGLE) N/A
Terminated NCT04809623 - Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE) Phase 1
Completed NCT01300208 - To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus Phase 2
Terminated NCT01470313 - A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus Phase 1
Completed NCT01146444 - Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE) N/A
Completed NCT03134222 - Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE) Phase 2
Completed NCT00470912 - Sunscreen RV 2457C in Photoinduced CLE Phase 3
Completed NCT01841619 - IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus Phase 0
Completed NCT00523588 - Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser Phase 2
Recruiting NCT06411106 - Deep Phenotyping of Cutaneous Lupus Erythematosus N/A
Not yet recruiting NCT06015737 - A 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus Phase 3
Terminated NCT01498406 - Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus Phase 2
Completed NCT04647708 - Study of M5049 in CLE and SLE Participants Phase 1
Completed NCT03817424 - A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis Phase 1
Active, not recruiting NCT03260166 - Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus Phase 2
Completed NCT00317681 - Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE) Phase 2
Completed NCT04781816 - Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus Phase 2